Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery

Completed · Phase 3

Conditions studied: Atrial Fibrillation, Atrial Flutter

In brief

The purpose of this study is to demonstrate the safety and efficacy of RSD1235 compared to placebo in the conversion of atrial arrhythmia to sinus rhythm in subjects following valvular and/or coronary artery bypass graft surgery.

Key facts

Study ID

NCT00125320

Run by

Astellas Pharma Inc

People needed

190

Starts

2004-06-01

Expected to finish

2007-02-01

Last updated by the study team

2007-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented atrial arrhythmia after valvular and/or coronary artery bypass graft surgery

You may not qualify if…

• Unstable Class IV heart failure

Where it is running

• Study site — Fort Lauderdale, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Buenos Aires, Argentina
• Study site — La Plata, Argentina
• Study site — Calgary, Alberta, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Montreal, Quebec, Canada
• Study site — Montreal, Quebec, Canada
• Study site — Aalborg, DK, Denmark
• Study site — Hellerup, DK, Denmark
• Study site — Odense C, DK, Denmark
• Study site — Bangalore, India
• Study site — Chennai, India
• Study site — Hyderabaad, India
• Study site — Kerala, India
• Study site — Mohali, India
• Study site — Mumbai, India
• Study site — New Delhi, India
• Study site — Katowice, Poland
• Study site — Krakow, Poland
• Study site — Lodz, Poland
• Study site — Warsaw, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.